Armstrong D., Isaacs J., Ottaviano Y., Davidson N. (1992). Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res52:3418-3424.
2.
Azzam H., Arand G., Lippman M., Thompson E. (1993). Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst85:1758-1764.
3.
Cornetta K., Moore A., Johannesohn M., Sledge G. (1994). Clonal dominance detected in metastases but not primary
4.
tumors of retrovirally-marked human breast carcinoma injected into nude mice . Clin Exp Met12:3-12.
5.
Davies B., Miles D., Happerfield L., Naylor M., Bobrow L., Rubens RD, et al. (1993). Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer67:1126-1131.
6.
DeClerck Y., Perez N., Shimada H., Boone T., Langley K., Taylor S. (1992). Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res52:701-708.
7.
Fife R., Sledge G. (1995). Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells. J Lab Clin Med125:407-411.
8.
Fife R., Sledge G., Dunn J., Proctor C., Houser D. (1994). Suppression of growth of primary breast cancer in mice treated with doxycycline (abstract). Clin Res42(A):394.
9.
Fife R., Sledge G., Proctor C., Dunn J. ( 1996). Doxycycline inhibits matrix metalloproteinase activity and enhances apoptosis in human prostate cancer cells (abstract). J Invest Med44(A):249.
10.
Fife RS, Rougraff BT, Proctor C., Sledge GW (1997). Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J Lab Clin Med130:530-534.
11.
Fife RS, Sledge GW, Roth BJ, Proctor C. (1998). Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett127:37-41.
12.
Furuya Y., Lundmo P., Short A., Gill D., Isaacs J. (1994). The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res54:6167-6175.
13.
Lee W., Aitken S., Kulkarni G., Birek P., Overall C., Sodek J., et al. (1991). Collagenase activity in recurrent periodontitis . J Periodont Res26:479-485.
14.
Liotta L., Tryggvason K., Garbisa S., Hart I., Foltz C., Shafie S. (1980). Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature284:67-68.
15.
Masumori N., Tsukamoto T., Miyao N., Kumamoto Y., Saiki I., Yoneda J. (1994). Inhibitory effect of minocycline on in vitro invasion and experimental metastasis of mouse renal adenocarcinoma. J Urol151:1400-1404.
16.
Moscatelli D., Rifkin D. (1988). Membrane and matrix localization of proteinases . Biochim Biophys Acta948:67-85.
17.
Price J., Bell C., Frost P. (1990a). The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a breast carcinoma in nude mice. Int J Cancer45:968-971.
18.
Price J., Polyzos A., Zhang R., Daniels L. (1990b). Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res50:717-721.
19.
Silverberg E., Boring CC, Squires TS (1990). Cancer statistics, 1990. CA Cancer J Clinicians40:9-26.
20.
Sledge G., Qulali M., Goulet R., Bone E., Fife R. ( 1995). Effect of MMP inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst87:1546-1550.
21.
Sledge G., Qulali M., Bone E., Fife R. ( 1996). Combination matrix metalloproteinase inhibition in an athymic mouse xenograft model of human breast cancer metastasis (abstract) . Proc Am Assoc Cancer Res37:92.
22.
Tamargo RJ, Bok RA, Brem H. ( 1991). Angiogenesis inhibition by minocycline. Cancer Res51:672-675.
23.
Teicher B., Holden S., Liu C., Ara G., Herman T. (1994). Minocycline as a modulator of chemotherapy and hyperthermia in vitro and in vivo. Cancer Lett82:17-25.
24.
Tilley B., Alarcon G., Heyse S., Trentham D., Neuner R., Kaplan D., et al. (1995). Minocycline in rheumatoid arthritis. Ann Int Med122:81-89.
25.
Van den Bogert C., Dontje B., Kroon A. (1985). The antitumour effect of doxycycline on a T-cell leukaemia in the rat. Leukemia Res9:617-623.
26.
Wakai K., Ohmura E., Satoh T., Marakami H., Isozaki 0, Emoto N., et al. (1994). Mechanisms of inhibitory actions of minocycline and doxycycline on ascitic fluid production induced by mouse fibrosarcoma cells. Life Sci54:703-709.
